Skip to main content
Studiju programma
Supervisor
Vladimirs Voicehovskis

Study Course Description

Course Description Statuss:Approved
Course Description Version:1.00
Study Course Information
Course Code:ISK_038LQF level:Level 7
Credit Points:1.00ECTS:1.50
Branch of Science:Medicine; Internal MedicineTarget Audience:Dentistry
Study Course Supervisor
Course Supervisor:Vladimirs Voicehovskis
Study Course Implementer
Structural Unit:Department of Internal Diseases
The Head of Structural Unit:Aivars Lejnieks
Contacts:Rīga, Hiprokrāta iela 2, iskatrsu[pnkts]lv, iskatrsu[pnkts]lv, +371 67042338
Study Course Planning
Full-Time - 1. Semester No.
Lectures (number)1Lecture Length (academic hours)2Total Contact Hours of Lectures2
Classes (number)6Class Length (academic hours)2Total Contact Hours of Classes12
Total Contact Hours14
Study course description
Preliminary Knowledge:
normal anatomy, histology, normal physiology, biochemistry, basics of medical physics, biology and basics of genetics, microbiology/immunology, internal diseases propaedeutics, skin and mouth mucosa diseases, oral morphology.
Objective:
1. To learn about the anamnesis compilation principles in determination or exclusion of rheumatologic diseases; 2. To learn the examination principles of peripheral joint and spine mobility; 3. To learn about the nature of a disease (pathogenesis, main mechanism, clinical manifestations), diagnostic (immunological analyses, radiological investigations) and therapy principles, prognosis; 4. To learn how to choose and interpret laboratory and instrumental investigation data, in case of various rheumatologic diseases; 5. To promote the development of students' clinical thinking.
Topic Layout (Full-Time)
No.TopicType of ImplementationNumberVenue
1The profile of a rheumatologic patient; Autoimmune inflammatory arthritis; Crystal-induced arthropathy; Connective tissue diseases; Vasculitis.Lectures1.00clinical base
2Working principles with rheumatologic patients in the practice of a physician and a dentist.Classes1.00clinical base
3Working principles with patients suffering from arthritis.Classes1.00clinical base
4Working principles with patients suffering from septic arthritis.Classes1.00clinical base
5Working principles with patients suffering from arthropathy.Classes1.00clinical base
6Working principles with patients suffering from connective tissue disease.Classes1.00clinical base
7Working principles with patients suffering from vasculitis.Classes1.00clinical base
Assessment
Unaided Work:
Acquisition of theoretical knowledge through scientific publications and literature, preparation of training materials for studies. The patient examination, analysis and interpretation of the investigation results, filling in the medical history.
Assessment Criteria:
An examination which consists of 3 parts: 1) A theoretical question about a rheumatologic disease (autoimmune inflammatory arthritis, osteoarthritis, crystal arthropathy, systemic connective tissue diseases, vasculitides) - brief characterization, main manifestations, diagnostic and therapy principles - 30%; 2) case study (the aim – to define the diagnosis, the differential diagnosis, investigation and treatment principles) - 40%; 3) Multiple choice questions (OSCE) - 30% of the total mark.
Final Examination (Full-Time):Test (Semester)
Final Examination (Part-Time):
Learning Outcomes
Knowledge:- to collect targeted anamnesis, to list and describe the musculoskeletal physical examination principles, to define the possible diagnosis assessing treatment safety. - to define aspects of pathogenesis, diagnosis (classification and diagnostic criteria) and therapy principles of rheumatologic diseases. - to analyse the obtained information and to define the diagnosis, to assess disease activity and prognosis. - to do histological interpretation of biopsy results and to describe their application in dentist’s practice - aspects of cooperation with a rheumatologist. - to describe emergency and urgent situations for rheumatologic patients in dentist’s practice.
Skills:The students are able to: -communicate with patients, their relatives, co-workers and other persons involved in health care. - collect a medical history. - perform patient's physical examination. - interpret laboratory and imaging results used in rheumatologic practice. - decide on treatment principles and therapeutic aspects of safety monitoring of rheumatologic diseases. - summarize the acquired symptoms and present the diagnosis and medical history.
Competencies:- to evaluate the obtained medical history, physical findings and to determine the diagnosis and the differential diagnosis/es. - to assemble and justify the necessary laboratory and radiological examination plan for confirmation of the diagnosis and exclusion of the differential diagnosis. - to interpret laboratory and radiological examination results. - to be competent in pathogenesis, diagnosis, treatment principles and variations of rheumatologic diseases. - to be able to analyse situations, substantiate, logically formulate and explain ones opinion.
Bibliography
No.Reference
1Oxford Textbook of Rheumatology;
2Sterling G. West. Rheumatology Secrets;
3Atlas of Rheumatology (edited by Gene G. Hunder)
1Bioloģisko slimību modificējošo antireimatisko medikamentu lietošanas vadlīnijas autoimūno iekaisumu artrītu ārstēšanā pieaugušajiem. Darba grupas vadītāja prof. Daina Andersone, 2011. gads
2EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifyin antirheumatic drugs. J. Smolen et al. Ann Rheum Dis. 2010 Jun; 69(6): 964-75
3EULAR recommendation for the management of early arthritis. Combe et al. Ann Rheum Dis 2007 Jan Vol. 66 No. 1, p. 34-45
4EULAR evidence based recommendations for the management of hand osteoarthritis – report of a task force of the EULAR Standing Committee for the International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, Mar 2007; 66: 377 – 388.
5EULAR evidence based recommendations for the management of hip osteoarthritis – report of a task force of the EULAR Standing Committee for the International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, Oct 2004; 64: 669-681.
6EULAR recommendation 2003: an evidence based approach to the management of knee osteoarthritis – report of a task force of the EULAR Standing Committee for the International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, Jul 2003; 62: 1145-1155.
7The Assessment of Spondyloarthritis International Society (ASAS) Handbook: a guide to assess spondyloarthritis. Siper J. et al. Ann Rheum Dis 2009; 68, suppl. 2.
82010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2011; 70:905-908.
9EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis 2012;71: 4-12.
10EULAR evidence based recommenations for gout. Part I: Diagnosis. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis Oct, 2006; 65: 1301-1311.
11EULAR evidence based recommenations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis May, 2006; 65: 1312-1324.
12EULAR recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis 2011; 70: 563-570.
13EULAR recommendations for calcium pyrophosphate deposition. Part II: mangement. Ann Rheum Dis 2011; 70: 571-575.
14Joint EULAR and European Renal Association- European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis, published 31 July 2012
15EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic disease. Ann Rheum Dis 2011; 70: 414-422.
16EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a tas force of the EULAR standing committee for clinical affairs. Ann Rheum Dis, 19 August 2010, online published
17EULAR recommendations for the treatment of systemic sclerosis: a repot task from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis, Jan 2009; 68: 620-628
18EULAR points to consider in the development of classification and diagnostic criateria in systemic vasculitis. Ann Rheum Dis 2010; 69:1744-1750
19EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, Feb 2008; 67: 195 – 205.
1http://www.asas-group.org/
2www.eular.com
3http://www.rheumatology.org/Practice/Clinical/Clinical_Supp…